Abstract:Background: Dilated Cardiomyopathy (DCM) frequently culminates in Heart Failure (HF), positioning it as the primary instigator of cardiac transplantation among pediatric patients. Nevertheless, the issue of cardiac transplantation in children demands a comprehensive and judicious strategy. Objectives: The aim of this research was to ascertain the clinical attributes at the point of diagnosis that could potentially signal the requirement for transplantation in pediatric patients diagnosed with Dilated Cardiomyopathy (DCM). Methods: In our study, we recognized 99 instances of pediatric cardiomyopathy accompanied by advanced heart failure (EF<30%). The patients were categorized into two cohorts, namely, the transplantation group and the non-transplantation group, based on whether they underwent cardiac transplantation. Each patient in both groups was administered conventional medication. Patients within the non-transplantation group demonstrated improved cardiac function following a minimum of six months of medication therapy. The identification of factors associated with heart transplantation in pediatric DCM was facilitated through the utilization of competing risks and multivariable modeling. Result: Out of a total of 99 children, 35 were recipients of transplants, henceforth referred to as the transplantation group, while the remaining 64, diagnosed with Dilated Cardiomyopathy (DCM), did not undergo transplantation, forming the non-transplantation group. A comparative analysis revealed no significant differences in age, gender, and weight between the two groups. However, the transplantation group demonstrated a significantly higher New York Heart Association (NYHA) class 4, incidence of galloping rhythm, hepatomegaly, morphological changes, ascites, and orthopnea in comparison to the non-transplantation group (all p<0.05).In the meantime, there was a significantly higher incidence of abnormal left ventricular end-diastolic diameter, aortic and pulmonary valve regurgitation rates, and incomplete myocardial compaction in the left ventricle within the transplant group as compared to the non-transplant group (p<0.05).Nonetheless, the analysis revealed no significant disparities in biochemical markers, which include BNP, CK-MB, CTnI, GOT, BUN, sCr, and GPT, between the two groups (all p>0.05). A univariate logistic regression analysis demonstrated that NYHA score [aOR (95%CI) = 2.78 (1.06-7.27), p=0.037], Ascites [aOR (95%CI) = 12.93 (2.45-68.22), p=0.003], and Left ventricular noncompaction [aOR (95%CI) = 3.73 (1.01-13.86), p=0.048] were all significantly correlated with the Transplantation group. Conclusions: Pediatric dilated cardiomyopathy (DCM) presenting with indicators of progressive heart failure, including an elevated New York Heart Association (NYHA) classification, ascites, and left ventricular non-compaction, necessitates increased vigilance. It is advised that these cases be closely monitored, and early consideration should be given to heart transplantation as a potential therapeutic intervention.

Chronotropic Response to Exercise is Decreased in Patients With Congenital Heart Disease Compared to Cardiomyopathy Following Pediatric Heart Transplantation

Indication for Pediatric Heart Transplant Affects Longitudinal Chronotropy on Cardiopulmonary Exercise Testing

Cardiopulmonary Exercise Testing—A Valuable Tool, Not Gatekeeper When Referring Patients With Adult Congenital Heart Disease for Transplant Evaluation

The Characteristics of Blood Transfusion and Analysis of Preoperative Factors Associated with Intraoperative Blood Transfusion in Congenital Heart Surgery: a Case–control Study

Cardiorespiratory function of pediatric heart transplant recipients in the early postoperative period

Effect of body mass index on exercise capacity following pediatric heart transplantation

Influence of cardiac diagnosis on outcomes of pediatric heart-lung transplantation

Critical Predictors of Heart Transplant Necessity in Children with Advanced DCM

Long-term outcomes of heart transplantation in adults with congenital heart disease: The impact of single-ventricle versus biventricular physiology

Heart Transplantation for Adults With Congenital Heart Disease Can Be Performed at Adult or Pediatric Hospitals With Comparable Outcomes

Pulmonary responses following cardiac rehabilitation and the relationship with functional outcomes in children and young adults with heart disease

Assessing the Role of Primary Heart Failure Etiology on Cardiac Transplant Outcomes

Pathology of explanted pediatric hearts: An 11‐year study. Population characteristics and implications for outcomes

Survival after Cardiac Transplantation in Patients with Hypertrophic Cardiomyopathy

Vascular and autonomic function in preschool-aged children with congenital heart disease.

Trends and outcomes of heart transplantation in adults with congenital heart disease

Abstract 11615: The Prevalence and Association of Exercise Test Abnormalities With Sudden Cardiac Death and Transplant-Free Survival in Childhood Hypertrophic Cardiomyopathy

Cardiac transplantation in pediatric patients: fifteen-year experience of a single center

Exercise Capacity in Children and Adolescents With Congenital Heart Disease: A Systematic Review and Meta-Analysis

Contemporary Trends and Risk Factors of Hemodynamic and Myocardial Mechanics Derived by the Pressure Recording Analytical Method After Pediatric Cardiopulmonary Bypass

Changes in waiting time, need for mechanical circulatory support and outcomes in paediatric heart transplant recipients